Get the Stockscreener App
1.14
2.23%
0.02
Bionano Genomics Inc stock is traded at $1.14, with a volume of 58,521.
It is up +2.23% in the last 24 hours and down -3.38% over the past month.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
See More
Previous Close:
$1.12
Open:
$1.14
24h Volume:
58,521
Relative Volume:
0.29
Market Cap:
$11.61M
Revenue:
$28.72M
Net Income/Loss:
$-38.59M
P/E Ratio:
-0.0734
EPS:
-15.5256
Net Cash Flow:
$-18.98M
1W Performance:
-0.43%
1M Performance:
-3.38%
6M Performance:
-68.54%
1Y Performance:
-71.01%
1-Day Range:
$1.11
$1.155
1-Week Range:
$1.0801
$1.18
52-Week Range:
$1.06
$5.50
Bionano Genomics Inc Stock (BNGO) Company Profile
Name
Bionano Genomics Inc
Sector
Industry
Phone
(858) 888-7600
Address
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA
Compare BNGO vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BNGO
Bionano Genomics Inc
|
1.141 | 11.40M | 28.72M | -38.59M | -18.98M | -15.53 |
|
ISRG
Intuitive Surgical Inc
|
502.04 | 176.65B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
171.18 | 49.56B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
84.00 | 40.50B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
258.90 | 37.63B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
43.12 | 36.02B | 28.43B | 1.16B | 1.26B | 1.4457 |
Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-15-24 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Sep-10-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Dec-12-22 | Resumed | BTIG Research | Buy |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Jun-16-21 | Initiated | BTIG Research | Buy |
| Sep-24-20 | Initiated | Ladenburg Thalmann | Buy |
| Apr-08-20 | Initiated | Oppenheimer | Outperform |
View All
Bionano Genomics Inc Stock (BNGO) Latest News
Bear Alert: What Wall Street predicts for Bionano Genomics Inc. stock priceJuly 2025 Selloffs & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
How labs aim to map 10,000 genomes a year with cheaper OGM tech - Stock Titan
Bionano Genomics (BNGO) Advances Insights into Genetic Disorders at Symposium 2026 - GuruFocus
10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM’s Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders - The Manila Times
New genome mapping tech finds hidden genetic changes in autism, pregnancy loss - Stock Titan
Operating cash flow per share of Bionano Genomics, Inc. – LSE:0A4K - TradingView
11 Presentations on Day 2 of Bionano Symposium 2026 Showcase Expanding Impact of Optical Genome Mapping Across Oncology and Cell & Gene Therapy - The Manila Times
Inside the tech spotting hidden cancer DNA errors and testing gene therapies - Stock Titan
Update Recap: Is Bionano Genomics Inc being accumulated by smart money2025 Technical Patterns & Weekly Stock Performance Updates - baoquankhu1.vn
Bionano Genomics (BNGO) Showcases Breakthroughs in Hematologic C - GuruFocus
9 Presentations Kick Off Day 1 of the Bionano Symposium 2026 Covering Advances in Optical Genome Mapping for Hematologic Malignancies - marketscreener.com
Scientists from 70 countries explore new DNA mapping tools for blood cancers - Stock Titan
Day Trade: Is BJs Wholesale Club Holdings Inc still a buy after recent gainsMarket Weekly Review & Safe Capital Allocation Plans - baoquankhu1.vn
MACD Signal: Is GSRT trading at a discountMarket Risk Report & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Growth Review: Is IGNEP trading at a discountWeekly Stock Summary & Short-Term Swing Trade Alerts - baoquankhu1.vn
BNGO SEC FilingsBionano Genomics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Insider at Bionano Genomics (BNGO) reports small 6-share tax-withholding disposition - Stock Titan
BNGO Should I Buy - Intellectia AI
Will Bionano Genomics Inc. outperform its industry peersQuarterly Portfolio Report & Low Drawdown Momentum Trade Ideas - mfd.ru
Momentum Shift: Will Bionano Genomics Inc outperform the market in YEARJuly 2025 Volume & High Win Rate Trade Tips - baoquankhu1.vn
Bionano Genomics (BNGO) to Host Virtual Symposium on Genome Mapp - GuruFocus
Bionano Announces Bionano Symposium 2026: Global Experts Showcase Advances and Innovation in Optical Genome Mapping - The Manila Times
Bionano Announces Bionano Symposium 2026: Global Experts - GlobeNewswire
Bionano Announces 4-Day 2026 OGM Symposium - National Today
Bionano study shows optical genome mapping detects gene editing alterations - Investing.com Nigeria
Bionano study shows optical genome mapping detects gene editing alterations By Investing.com - Investing.com South Africa
Bionano Announces Publication from Sanford Burnham Prebys Medical Discovery Institute Describing use of OGM to Detect Genomic Alterations Introduced by Gene Editing Technologies - The Manila Times
Bionano Announces Publication from Sanford Burnham Prebys - GlobeNewswire
Is Bionano Genomics Inc benefiting from interest rate changesChart Signals & Verified Swing Trading Watchlists - baoquankhu1.vn
Market Cool On Bionano Genomics, Inc.'s (NASDAQ:BNGO) Revenues - simplywall.st
Will Bionano Genomics Inc. outperform the market in YEARWeekly Profit Recap & Expert Verified Stock Movement Alerts - mfd.ru
Is Black Diamond Therapeutics (BDTX) Stock Outpacing Its Medical Peers This Year? - Nasdaq
Does US Foods Holding Corp stock benefit from AI growthPortfolio Return Summary & Real-Time Market Trend Scan - baoquankhu1.vn
H.C. Wainwright reiterates Buy rating on Bionano Genomics stock with $7 target - Investing.com Canada
Analysts Offer Insights on Healthcare Companies: Upstream Bio, Inc. (UPB) and BioNano Genomics (BNGO) - The Globe and Mail
Analyst Calls: Will Bionano Genomics Inc stock benefit from sector rotationJuly 2025 Fed Impact & Community Trade Idea Sharing Platform - Bộ Nội Vụ
Resistance Check: How Bionano Genomics Inc stock reacts to oil prices2025 Key Highlights & Community Consensus Picks - Bộ Nội Vụ
Investment Review: Will Bionano Genomics Inc stock benefit from green energy trendsShare Buyback & Expert Approved Trade Ideas - Bộ Nội Vụ
Bionano (BNGO) Strengthens Foundation with Strategic Advances in 2025 - GuruFocus
Bionano Genomics Reports Preliminary Fourth Quarter and Full-Year 2025 Results - TradingView
Bionano Reports Preliminary Fourth Quarter and Full-Year 2025 Results - marketscreener.com
Will Bionano Genomics Inc. stock attract more institutional investorsDividend Hike & Verified Technical Signals - ulpravda.ru
Geopolitics Watch: Will Bionano Genomics Inc. stock attract more institutional investorsMarket Movement Recap & Verified Swing Trading Watchlist - ulpravda.ru
Will Bionano Genomics Inc. stock split attract more investors2026 world cup usa national team round of 16 defensive leaders transition play knockout prediction guide - ulpravda.ru
Is Bionano Genomics Inc a good long term investmentStock Buyback Announcements & Free Stay Ahead With Picks - earlytimes.in
5 Biotech Stocks We Like in 2026. And 5 We Don’t - Nanalyze
VIX Spike: Can Bionano Genomics Inc stock beat analyst upgradesJuly 2025 Sentiment & Weekly Stock Breakout Alerts - moha.gov.vn
Aug Gainers: Will Bionano Genomics Inc stock see PE expansionMarket Activity Recap & Low Drawdown Trading Techniques - moha.gov.vn
Breakout Move: Will Bionano Genomics Inc stock see PE expansionEarnings Trend Report & Consistent Income Trade Recommendations - moha.gov.vn
How Low Can Bionano Genomics Stock Really Go? - Trefis
Bionano Genomics Earnings Notes - Trefis
Bionano Genomics Inc Stock (BNGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
2.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):